Centrus Energy's effort to move from demonstration-scale HALEU production to continuous commercial operations is being financed through an unusual combination of federal contracting, private convertible debt, and public equity — a capital stack that offers a template for how Western HALEU capacity may be funded.

The Federal Anchor

The company holds a $900 million base contract from the Department of Energy, extendable up to $1.07 billion with options. Crucially, that contract transitions Centrus's initial HALEU demonstration cascades into continuous commercial-scale operations rather than one-off production runs.

The commercial target at the American Centrifuge Plant in Piketon, Ohio, is at least 12 tonnes of HALEU annually, produced alongside scaled commercial LEU processing. HALEU — uranium enriched above 5 percent but below 20 percent uranium-235 — is the fuel specification for many advanced reactor designs, and the absence of a mature Western supply chain has been a persistent concern for developers.

Private Capital Layers

Public support is only part of the picture. Centrus raised more than $1.2 billion through convertible notes in late 2024 and mid-2025. In September 2026, it completed a secondary public offering that added $99.8 million for buildout liquidity.

Centrus holds an LEU backlog worth $2.3 billion to $3.7 billion in conditional sales commitments from domestic and international utilities.

That existing LEU pipeline matters for the economics of expansion. Enrichment plants benefit from scale, and LEU revenue from conventional utilities can underwrite the fixed costs of a facility that also produces smaller volumes of higher-assay material.

Labour and Regional Economics

The physical buildout is labour-intensive. Centrus expects 1,000 temporary construction jobs and 300 permanent operating roles in Pike County, Ohio, paired with hundreds of high-wage advanced manufacturing positions in Tennessee.

In East Tennessee, Centrus plans to hire 430 people and invest $560 million by 2030, expanding facilities and manufacturing capacity on its 80-acre Oak Ridge campus where the AC100M centrifuges are built.

What to Watch

The key question for the market is timing. Demonstration cascades have proven the technology; the commercial ramp depends on financing execution, component supply, and regulatory throughput. Centrus's willingness to spend on vertical integration — including its recent $116 million acquisition of centrifuge hardware supplier Westerman Holdings — signals that management sees schedule risk, not demand risk, as the binding constraint.

This article was assisted by AI analysis. Please refer to the original source for official information.